Every year, on October 1st, is World Urticaria Day, a day dedicated to raising awareness about urticaria, commonly known as ...

A little over a year ago, I woke up in the middle of the night with an itchy scalp. I didn’t give it much thought, assuming ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria ... estimates that there are around 400,000 people ...

Find out if a biologic is a good option for treating chronic spontaneous urticaria (CSU), also called chronic hives.

Omalizumab biosimilar is under clinical development by Kashiv BioSciences and currently in Phase III for Chronic Urticaria Or Hives. According to GlobalData, Phase III drugs for Chronic Urticaria Or ...

Povorcitinib phosphate is under clinical development by Incyte and currently in Phase II for Chronic Urticaria Or Hives. According to GlobalData, Phase II drugs for Chronic Urticaria Or Hives have a ...

How does urticaria affect daily life? Chronic urticaria can cause significant impairment in the patient’s quality of life due to associated pruritus and loss of sleep. It can hurt work, school, social ...

There may be an underlying cause for your hives that needs to be diagnosed ... Hives: self-care. Schaefer P. Acute and chronic urticaria: evaluation and treatment. Am Fam Physician. 2017;95(11):717-24 ...

met the primary and key secondary endpoints for the investigational treatment of patients with uncontrolled, biologic-naïve chronic spontaneous urticaria (CSU) receiving background therapy with ...

Novartis' big-selling IgE inhibitor Xolair has been a mainstay of treatment for refractory chronic spontaneous urticaria (CSU ... according to Novartis. There were "clinically meaningful and ...